| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0008 |